Korean J Health Promot.  2013 Mar;13(1):1-7.

The Relationship Between Serum Total Bilirubin and Framingham Risk Score in Healthy Korean Men

Affiliations
  • 1Department of Family Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea. fmewha@naver.com

Abstract

BACKGROUND
Serum total bilirubin has been considered a harmful substance inducing oxidative reaction; but recently, there have been reports of it possessing antioxidative, anti-inflammatory and protective features against cardiovascular diseases. The purpose of this study was to investigate the relationship between total bilirubin and the Framingham risk score.
METHODS
This study involved 3,414 healthy Korean men who underwent a medical check-up in a health promotion center in 2008. We calculated the Framingham risk score using age, smoking status, systolic blood pressure, total cholesterol and high-density lipoprotein cholesterol.
RESULTS
The mean age of the participants was 44.9+/-8.8 years. The log transformed serum total bilirubin level and the Framingham risk score had a negative linear relationship in a simple linear regression analysis (R2: 0.018, P<0.001). In a multivariable analysis model, as well, the log transformed serum total bilirubin level and the Framingham risk score had a negative linear relationship (R2: 0.384, P<0.001).
CONCLUSIONS
Our study showed a statistically significant negative relationship between total bilirubin and the Framingham risk score. Total bilirubin had a stronger relationship with the Framingham risk score than other standard cardiovascular risk factors except smoking, and thus may be useful in predicting cardiovascular risk in the outpatient clinic.

Keyword

Total bilirubin; Framingham risk score; Cardiovascular disease

MeSH Terms

Ambulatory Care Facilities
Bilirubin
Blood Pressure
Cardiovascular Diseases
Cholesterol
Health Promotion
Humans
Linear Models
Lipoproteins
Male
Risk Factors
Smoke
Smoking
Bilirubin
Cholesterol
Lipoproteins
Smoke
Full Text Links
  • KJHP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr